161 related articles for article (PubMed ID: 9183179)
21. Screening for ligands of human retinoid X receptor-alpha using ultrafiltration mass spectrometry.
Liu D; Guo J; Luo Y; Broderick DJ; Schimerlik MI; Pezzuto JM; van Breemen RB
Anal Chem; 2007 Dec; 79(24):9398-402. PubMed ID: 17997524
[TBL] [Abstract][Full Text] [Related]
22. Measurements of drug-protein binding by using immobilized human serum albumin liquid chromatography-mass spectrometry.
Cheng Y; Ho E; Subramanyam B; Tseng JL
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):67-73. PubMed ID: 15282095
[TBL] [Abstract][Full Text] [Related]
23. Salicylate binding by human albumin in the presence of a perfluorochemical emulsion.
Parsons DL; Sathe RS
Arch Int Pharmacodyn Ther; 1991; 310():5-12. PubMed ID: 1772331
[TBL] [Abstract][Full Text] [Related]
24. Metabolic screening using on-line ultrafiltration mass spectrometry.
van Breemen RB; Nikolic D; Bolton JL
Drug Metab Dispos; 1998 Feb; 26(2):85-90. PubMed ID: 9456292
[TBL] [Abstract][Full Text] [Related]
25. Development of a method to screen and isolate potential α-glucosidase inhibitors from Panax japonicus C.A. Meyer by ultrafiltration, liquid chromatography, and counter-current chromatography.
Li S; Tang Y; Liu C; Zhang Y
J Sep Sci; 2015 Jun; 38(12):2014-23. PubMed ID: 25847676
[TBL] [Abstract][Full Text] [Related]
26. Immunoaffinity Ultrafiltration with Ion Spray HPLC/MS for Screening Small-Molecule Libraries.
Wieboldt R; Zweigenbaum J; Henion J
Anal Chem; 1997 May; 69(9):1683-91. PubMed ID: 21639291
[TBL] [Abstract][Full Text] [Related]
27. Kinetics of inhibition of calf intestinal adenosine deaminase by (+)- and (-)-erythro-9-(2-hydroxy-3-nonyl)adenine.
Porter DJ; Abushanab E
Biochemistry; 1992 Sep; 31(35):8216-20. PubMed ID: 1525161
[TBL] [Abstract][Full Text] [Related]
28. Identification of inhibitors of the antibiotic-resistance target New Delhi metallo-β-lactamase 1 by both nanoelectrospray ionization mass spectrometry and ultrafiltration liquid chromatography/mass spectrometry approaches.
Chen X; Li L; Chen S; Xu Y; Xia Q; Guo Y; Liu X; Tang Y; Zhang T; Chen Y; Yang C; Shui W
Anal Chem; 2013 Aug; 85(16):7957-65. PubMed ID: 23863032
[TBL] [Abstract][Full Text] [Related]
29. Adenosine deaminase inhibitors: synthesis and structure-activity relationships of imidazole analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Cristalli G; Eleuteri A; Franchetti P; Grifantini M; Vittori S; Lupidi G
J Med Chem; 1991 Mar; 34(3):1187-92. PubMed ID: 2002459
[TBL] [Abstract][Full Text] [Related]
30. Salsalate and salicylate binding to and their displacement of thyroxine from thyroxine-binding globulin, transthyrin, and albumin.
Wang R; Nelson JC; Wilcox RB
Thyroid; 1999 Apr; 9(4):359-64. PubMed ID: 10319941
[TBL] [Abstract][Full Text] [Related]
31. Interaction of folic acid and some matrix metalloproteinase (MMP) inhibitor folate-γ-hydroxamate derivatives with Zn(II) and human serum albumin.
Enyedy EA; Farkas E; Dömötör O; Santos MA
J Inorg Biochem; 2011 Mar; 105(3):444-53. PubMed ID: 21421131
[TBL] [Abstract][Full Text] [Related]
32. Affinity selection and mass spectrometry-based strategies to identify lead compounds in combinatorial libraries.
Kaur S; McGuire L; Tang D; Dollinger G; Huebner V
J Protein Chem; 1997 Jul; 16(5):505-11. PubMed ID: 9246636
[TBL] [Abstract][Full Text] [Related]
33. An ultrafiltration and high performance liquid chromatography coupled with diode array detector and mass spectrometry approach for screening and characterizing thrombin inhibitors from Rhizoma Chuanxiong.
Zhang Q; Yang YX; Li SY; Wang YL; Yang FQ; Chen H; Xia ZN
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():421-429. PubMed ID: 28818799
[TBL] [Abstract][Full Text] [Related]
34. Drug-protein binding of Danhong injection and the potential influence of drug combination with aspirin: Insight by ultrafiltration LC-MS and molecular modeling.
Zhu J; Yi X; Huang P; Chen S; Wu Y
J Pharm Biomed Anal; 2017 Feb; 134():100-107. PubMed ID: 27889668
[TBL] [Abstract][Full Text] [Related]
35. The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation.
Kayhan N; Funke B; Conzelmann LO; Winkler H; Hofer S; Steppan J; Schmidt H; Bardenheuer H; Vahl CF; Weigand MA
Crit Care; 2008; 12(5):R125. PubMed ID: 18847498
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a large and flexible region of human serum albumin possessing high affinity binding sites for salicylate, warfarin, and other ligands.
Kragh-Hansen U
Mol Pharmacol; 1988 Aug; 34(2):160-71. PubMed ID: 3412320
[TBL] [Abstract][Full Text] [Related]
37. Adenosine deaminase inhibitors. Synthesis of deaza analogues of erythro-9-(2-hydroxy-3-nonyl)adenine.
Antonini I; Cristalli G; Franchetti P; Grifantini M; Martelli S; Lupidi G; Riva F
J Med Chem; 1984 Mar; 27(3):274-8. PubMed ID: 6699873
[TBL] [Abstract][Full Text] [Related]
38. Inhibitor screening using immobilized enzyme reactor chromatography/mass spectrometry.
Hodgson RJ; Besanger TR; Brook MA; Brennan JD
Anal Chem; 2005 Dec; 77(23):7512-9. PubMed ID: 16316156
[TBL] [Abstract][Full Text] [Related]
39. Specific and non-specific ligand binding to serum albumin.
Taira Z; Terada H
Biochem Pharmacol; 1985 Jun; 34(11):1999-2005. PubMed ID: 4004916
[TBL] [Abstract][Full Text] [Related]
40. Mass spectrometry and immobilized enzymes for the screening of inhibitor libraries.
Cancilla MT; Leavell MD; Chow J; Leary JA
Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12008-13. PubMed ID: 11035807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
